These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 16758897)

  • 1. [Influence of genetic and phenotypical factors on the efficiency of the vaccination of young children against diphtheria and measles].
    Gordeeva LA; Shabaldin AV; Semenova EM; Glushkov AN
    Zh Mikrobiol Epidemiol Immunobiol; 2006; (2):42-6. PubMed ID: 16758897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-specific immunological effects of selected routine childhood immunisations: systematic review.
    Kandasamy R; Voysey M; McQuaid F; de Nie K; Ryan R; Orr O; Uhlig U; Sande C; O'Connor D; Pollard AJ
    BMJ; 2016 Oct; 355():i5225. PubMed ID: 27737830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum anti-tetanus and measles antibody titres in Ugandan children aged 4 months to 6 years: implications for vaccine programme.
    Warrener L; Bwogi J; Andrews N; Samuel D; Kabaliisa T; Bukenya H; Brown K; Roper MH; Featherstone DA; Brown D
    Epidemiol Infect; 2018 Jul; 146(9):1151-1156. PubMed ID: 29739482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EPI vaccines-induced antibody prevalence in 8-9 year-olds in The Gambia.
    Viviani S; Mendy M; Jack AD; Hall AJ; Montesano R; Whittle HC
    Trop Med Int Health; 2004 Oct; 9(10):1044-9. PubMed ID: 15482396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited Impact of Human Cytomegalovirus Infection in African Infants on Vaccine-Specific Responses Following Diphtheria-Tetanus-Pertussis and Measles Vaccination.
    Cox M; Adetifa JU; Noho-Konteh F; Njie-Jobe J; Sanyang LC; Drammeh A; Plebanski M; Whittle HC; Rowland-Jones SL; Robertson I; Flanagan KL
    Front Immunol; 2020; 11():1083. PubMed ID: 32582177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intermittent preventive treatment for malaria during infancy on serological responses to measles and other vaccines used in the Expanded Programme on Immunization: results from five randomised controlled trials.
    Crawley J; Sismanidis C; Goodman T; Milligan P;
    Lancet; 2012 Sep; 380(9846):1001-10. PubMed ID: 22850358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral immunity of dTap-IPV vaccine (REPEVAX®) administered one month after dT-IPV vaccine (REVAXIS®) in adults with unknown vaccination history.
    Larnaudie S; Guiso N; Baptiste C; Desaint C; Desforges L; Lebon P; Soubeyrand B; Launay O
    Hum Vaccin; 2010 Oct; 6(10):829-34. PubMed ID: 20864810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epidemiological and immunological assessment of a schedule of prophylactic inoculations].
    Rusakova EV; Kashliaeva TK; Gusarova LD; Muradova GD
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Mar; (3):29-33. PubMed ID: 2954343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody response of children to measles vaccine mixed with diphtheria-pertussis-tetanus or diphtheria-pertussis-tetanus-poliomyelitis vaccine.
    Simoes EA; Balraj V; Selvakumar R; John TJ
    Am J Dis Child; 1988 Mar; 142(3):309-11. PubMed ID: 3257842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous administration of smallpox, measles, yellow fever, and diphtheria-pertussis-tetanus antigens to Nigerian children.
    Ruben FL; Smith EA; Foster SO; Casey HL; Pifer JM; Wallace RB; Atta AI; Jones WL; Arnold RB; Teller BE; Shaikh ZQ; Lourie B; Eddins DL; Doko SM; Foege WH
    Bull World Health Organ; 1973; 48(2):175-81. PubMed ID: 4541683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK.
    Marlow R; Kuriyakose S; Mesaros N; Han HH; Tomlinson R; Faust SN; Snape MD; Pollard AJ; Finn A
    Vaccine; 2018 Apr; 36(17):2300-2306. PubMed ID: 29576304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Collective immunity to diphtheria in the children and adolescents of Vladivostok during a mass immunization against this infection].
    Besednova NN; Kudrina NV; Kuznetsova TA; Zaporozhets TS; Lunika IG; Belogolovkina NA; Ivanova NIu; Voronok VM
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (5):82-4. PubMed ID: 9432857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody levels to diphtheria, tetanus, and rubella in infants vaccinated while on PD: a Study of the Pediatric Peritoneal Dialysis Study Consortium.
    Neu AM; Warady BA; Furth SL; Lederman HM; Fivush BA
    Adv Perit Dial; 1997; 13():297-9. PubMed ID: 9440877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasible improvements in vaccines in the Expanded Programme on Immunization.
    McIntosh K
    Rev Infect Dis; 1989; 11 Suppl 3():S530-7. PubMed ID: 2669097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A comparative evaluation of the immunological efficacy of ADPT vaccine and ADT-M anatoxin in the immunization of children against diphtheria and tetanus].
    Rusakova EV; Bezuglova MS; Vasil'eva VI; Frank KD; Panina GM
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Jul; (7):52-5. PubMed ID: 1950266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of nematode invasiveness in children on postvaccinal immunity].
    Lysenko AIa; Fel'dman EV; Rybak EA
    Med Parazitol (Mosk); 1991; (5):34-6. PubMed ID: 1836830
    [No Abstract]   [Full Text] [Related]  

  • 17. Malaria chemoprophylaxis and the serologic response to measles and diphtheria-tetanus-whole-cell pertussis vaccines.
    Rosen JB; Breman JG; Manclark CR; Meade BD; Collins WE; Lobel HO; Saliou P; Roberts JM; Campaoré P; Miller MA
    Malar J; 2005 Nov; 4():53. PubMed ID: 16271153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody titers and immune response to diphtheria-tetanus-pertussis and measles-mumps-rubella vaccination in children treated for acute lymphoblastic leukemia.
    Ercan TE; Soycan LY; Apak H; Celkan T; Ozkan A; Akdenizli E; Kasapçopur O; Yildiz I
    J Pediatr Hematol Oncol; 2005 May; 27(5):273-7. PubMed ID: 15891564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
    Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
    Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A REGIMEN FOR IMMUNIZATION AGAINST MEASLES. INACTIVATED VACCINE WITH DPT AND LIVE VACCINE AT AGE 9 MONTHS.
    KARELITZ S; SCHLUEDERBERG A; KANCHANAVATEE P; ARAI M; ACS H
    JAMA; 1965 Mar; 191():1067-70. PubMed ID: 14261887
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.